Renaissance Capital logo

bgne News

US IPO Weekly Recap: An active week as 7 IPOs average 16% pop

CELC

Seven deals raised a combined $1.2 billion this past week and first day returns averaged 16%. Performance was particularly strong for the healthcare space; Chinese cancer biotech Zai Lab led the pack, returning 55% on its first day, followed by Celcuity, which returned 50% and Krystal Biotech returned 6%. Latin...read more

US IPO Weekly Recap: A SPAC and a Reg A+ price; two billion-dollar companies file

CIC.U

Two IPOs raised a combined $380 million this past week. Blank check company Capitol Investment Corp. IV led the way with a $350 million offering, and branded content curator Chicken Soup for the Soul Entertainment followed with a Reg A+ offering that raised $30 million. Filing activity remained slow with just two companies joining the pipeline, along with a handful of updates. We...read more

Are US IPOs of Chinese companies a safe bet on the first day?

COE

Even as the 2016 IPO market lags the prior year by deal count (34 IPOs; -53%), proceeds ($5.5B raised; -58%) and filings (49 submissions; -54%), US IPO activity of China-based companies has kept pace with 2015. Including Thursday's China Online Education (51Talk; COE), the three Chinese companies listing in the US have raised more proceeds...read more

Renaissance Capital's 1Q16 US IPO Market Review

EDIT

The US IPO market in the 1Q16 hit its lowest levels since the depths of the financial crisis in 2008/2009. Not a single deal priced outside of the health care sector, where eight deals managed to raise $0.7 billion thanks to substantial buying by their existing shareholders. The resulting low tradable float also helped to prop up performance, and IPOs averaged a return of 25%, even...read more